Literature DB >> 6616455

Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney.

J J Li, S A Li, J K Klicka, J A Parsons, L K Lam.   

Abstract

Both synthetic and natural estrogens have been studied for their ability to induce renal carcinomas in castrated male hamsters after 9.0 months of treatment. Tumor foci were detected in frozen serial sections stained histochemically for estrase activity. Both diethylstilbestrol (DES) and 17 beta-estradiol had equal ability (100%) to induce renal tumors [approximately 20.5 +/- 3 (S.E.) tumor foci] in these animals. Hexestrol induced the same incidence and number of renal carcinoma foci as DES or 17 beta-estradiol. However, alpha -dienestrol and DES 3,4-oxide showed an 86 to 88% incidence of renal tumors in hamsters (approximately 10.8 +/- 3). When equilin and d-equilenin, components of therapeutic conjugated estrogens, were tested, only equilin had a 76% incidence of renal tumor foci (5.5 +/- 0.9). The ability of these stilbene and steroidal estrogens to compete for renal tumor estrogen receptor generally correlated well with their ability to cause renal tumorigenesis in the hamster with one notable exception. Although ethinyl estradiol competed as well as did DES or 17 beta-estradiol for estrogen receptor, had similar ability to induce renal progesterone receptor, and led to similar high serum prolactin levels as either DES or 17 beta-estradiol, it had only weak carcinogenic activity (21%) in the hamster kidney (0.6 +/- 0.5 foci). These data represent the first detailed analysis of the relative carcinogenic activity of different estrogens within a given tumor-inducing system, and based on the carcinogenicity data of hexestrol and alpha-dienestrol presented herein, they suggest that epoxidation of the olefinic double bond and the p-quinone metabolite of DES probably are not involved significantly in its carcinogenic activity. Moreover, the poor carcinogenic activity of ethinyl estradiol in this system, despite strong estrogenicity, suggests that estronic activity alone may not be sufficient to effect renal tumorigenesis in the hamster.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6616455

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

Review 1.  The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.

Authors:  Ercole Cavalieri; Eleanor Rogan
Journal:  Mol Aspects Med       Date:  2013-08-30

Review 2.  The role of estrogen in the initiation of breast cancer.

Authors:  J Russo; Irma H Russo
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12       Impact factor: 4.292

3.  Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men.

Authors:  Inik Chang; Shinichiro Fukuhara; Darryn K Wong; Ankurpreet Gill; Yozo Mitsui; Shahana Majid; Sharanjot Saini; Soichiro Yamamura; Takeshi Chiyomaru; Hiroshi Hirata; Koji Ueno; Sumit Arora; Varahram Shahryari; Guoren Deng; Z Laura Tabatabai; Kirsten L Greene; Dong Min Shin; Hideki Enokida; Hiroaki Shiina; Norio Nonomura; Rajvir Dahiya; Yuichiro Tanaka
Journal:  Tumour Biol       Date:  2014-07-17

Review 4.  Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers.

Authors:  Ercole L Cavalieri; Eleanor G Rogan
Journal:  Future Oncol       Date:  2010-01       Impact factor: 3.404

5.  In vitro modulation of antioxidant enzymes in normal and malignant renal epithelium.

Authors:  A H Yang; T D Oberley; L W Oberley; S M Schmid; K B Cummings
Journal:  In Vitro Cell Dev Biol       Date:  1987-08

6.  Risk factors for renal cell carcinoma: results of a population-based case-control study.

Authors:  N Kreiger; L D Marrett; L Dodds; S Hilditch; G A Darlington
Journal:  Cancer Causes Control       Date:  1993-03       Impact factor: 2.506

7.  Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators.

Authors:  E L Cavalieri; D E Stack; P D Devanesan; R Todorovic; I Dwivedy; S Higginbotham; S L Johansson; K D Patil; M L Gross; J K Gooden; R Ramanathan; R L Cerny; E G Rogan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

8.  Mechanism of metabolic activation and DNA adduct formation by the human carcinogen diethylstilbestrol: the defining link to natural estrogens.

Authors:  Muhammad Saeed; Eleanor Rogan; Ercole Cavalieri
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

9.  The etiology and prevention of breast cancer.

Authors:  Ercole L Cavalieri; Eleanor G Rogan
Journal:  Drug Discov Today Dis Mech       Date:  2012

10.  Experimental models of kidney tumors.

Authors:  E Nogueira; A Cardesa; U Mohr
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.